의료 및 헬스케어 기기용 배터리 시장 예측(2026-2032년)

The Batteries for Medical & Healthcare Device Market is projected to grow by USD 3.98 billion at a CAGR of 7.51% by 2032.

Medical Device Batteries: Executive Overview

Batteries for medical and healthcare devices support diagnosis, monitoring, treatment, mobility, emergency care, and home-based services. The field spans primary and rechargeable chemistries, compact cells, battery packs, power-management systems, and related safety controls. Demand is shaped by device miniaturization, greater use of portable equipment, stricter reliability requirements, and the need for uninterrupted operation in clinical and home settings. Product selection depends on energy density, operating life, rechargeability, sterilization compatibility, leakage resistance, transport requirements, and regulatory compliance.

Portability, Reliability, and Regulation Reshape Device Power

Medical equipment is becoming more portable, connected, and distributed across hospitals, ambulances, outpatient facilities, and homes. This shift increases the importance of lightweight designs, rapid charging, long standby duration, accurate state-of-charge monitoring, and dependable performance during transport or emergency use. At the same time, manufacturers must address traceability, thermal safety, electromagnetic compatibility, cybersecurity for connected battery-management systems, and responsible end-of-life handling. Supply-chain resilience is also increasingly important because specialized cells, electronic components, and tested assemblies may require qualified alternative sources.

Artificial Intelligence Improves Battery Design and Clinical Reliability

Artificial intelligence is contributing to battery-related workflows through predictive maintenance, remaining-useful-life estimation, anomaly detection, demand planning, and quality inspection. Algorithms can analyze charge-discharge histories, temperature behavior, impedance, and device-use patterns to identify degradation before failure. In connected medical devices, AI-assisted power management may help balance performance and battery life by adapting operation to workload. These benefits depend on representative data, validated models, explainable alerts, strong cybersecurity, and human oversight. AI should complement, rather than replace, documented engineering verification and medical-device quality controls.

Regional Dynamics: Diverse Regulatory and Care-Delivery Priorities

North America emphasizes advanced connected devices, home healthcare, emergency response, and stringent safety and quality expectations. Latin America is shaped by uneven healthcare access, import dependencies, infrastructure variation, and demand for durable equipment suited to challenging operating conditions. Europe combines strong medical-device regulation with sustainability, circularity, recycling, and energy-efficiency priorities. The Middle East is supported by healthcare modernization, specialist hospitals, and expanding remote and mobile services, while procurement often places emphasis on reliability and harsh-environment performance. Africa presents opportunities linked to decentralized care, diagnostic access, backup power, and equipment that can withstand limited service infrastructure. Asia-Pacific combines large-scale device manufacturing, strong electronics capabilities, aging populations, expanding healthcare access, and varied national regulatory environments.

Group Insights: Trade, Standards, and Healthcare Coordination

ASEAN reflects diverse healthcare systems and manufacturing bases, making harmonized regulatory practices, dependable logistics, and localized service important. BRICS members combine significant healthcare demand with varied industrial capabilities, domestic-production objectives, and differing approval frameworks. The European Union places strong emphasis on product safety, environmental responsibility, documentation, and cross-border regulatory consistency. G7 markets generally prioritize advanced clinical technologies, resilient supply chains, quality systems, and lifecycle accountability. GCC countries are investing in healthcare infrastructure and specialized services, increasing the importance of reliable equipment for hospitals, transport, and home care. NATO members share broad concerns around medical readiness, interoperability, secure supply, and dependable operation in demanding environments, while national procurement rules remain relevant.

Country Insights Across Major Medical-Device Ecosystems

Australia's geographically dispersed care model supports interest in portable, robust, and serviceable equipment. Brazil's large and varied healthcare system increases the importance of cost-conscious design, local support, and regulatory execution. Canada's remote communities and home-care needs favor dependable portable devices and strong cold-chain and logistics planning. China combines substantial device production with expanding domestic healthcare demand and localization priorities. France, Germany, Italy, and Spain operate within the European regulatory environment while maintaining distinct clinical procurement and industrial strengths. India's expanding healthcare access and manufacturing ambitions support demand for scalable, durable, and affordable battery solutions. Japan emphasizes miniaturization, precision, aging-related care, and high reliability. Mexico benefits from medical manufacturing integration and regional supply-chain links. Russia's market conditions are influenced by domestic supply considerations, import constraints, and healthcare infrastructure needs. South Korea combines advanced electronics expertise with sophisticated medical-device development. The United Kingdom emphasizes regulated clinical use, home healthcare, and supply resilience following changes in its trading and regulatory environment. The United States remains a major center for medical innovation, connected care, emergency equipment, and rigorous product qualification.

Priorities for Leaders: Build Safety, Resilience, and Lifecycle Value

Industry leaders should segment battery requirements by device risk, use environment, duty cycle, and clinical consequence of failure rather than treating all applications alike. They should qualify multiple sources where feasible, document chemistry and component traceability, and test performance across temperature, vibration, storage, transport, sterilization, and abnormal-use conditions. Battery-management systems should include validated monitoring, thermal safeguards, fault logging, and secure software practices. Design teams should plan for repair, replacement, recycling, and safe disposal from the outset. Commercial and engineering functions should also collaborate with clinicians, regulators, distributors, and service organizations to align battery performance with real-world workflows and total lifecycle needs.

Research Methodology: Structured Review of Medical Power Requirements

This executive summary uses a structured, qualitative review of the batteries-for-medical-and-healthcare-device domain. The assessment organizes findings around device portability, reliability, rechargeability, safety, regulation, sustainability, digital monitoring, healthcare delivery, and supply-chain conditions. Regional, group, and country observations are synthesized from established differences in healthcare infrastructure, industrial capability, regulatory context, demographic pressures, and care settings. Artificial-intelligence implications are evaluated by considering documented uses in predictive maintenance, quality control, and power optimization. No market estimates, market shares, forecasts, or company-specific claims are used.

Conclusion: Battery Performance Is Integral to Medical Device Trust

Medical-device batteries are becoming a strategic component of clinical safety, mobility, connectivity, and continuity of care. Success requires more than selecting a high-performing cell: it depends on system-level engineering, validated monitoring, regulatory discipline, resilient sourcing, and responsible lifecycle management. Regional and country conditions differ, but the common direction is toward smaller, smarter, safer, and more serviceable power systems. Organizations that integrate battery expertise early into device design and deployment can better support reliable care across hospitals, emergency settings, and the home.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. New Revenue Opportunities
• 3.4. Next-Generation Business Models
• 3.5. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Batteries for Medical & Healthcare Device Market, by Chemistry

• 7.1. Introduction
• 7.2. Alkaline
• 7.3. Lead Acid
• 7.4. Lithium Ion
• 7.5. Nickel Metal Hydride

8. Batteries for Medical & Healthcare Device Market, by Rechargeability

• 8.1. Introduction
• 8.2. Primary
• 8.3. Rechargeable
  • 8.3.1. Lithium Ion Rechargeable
  • 8.3.2. Nickel Metal Hydride Rechargeable

9. Batteries for Medical & Healthcare Device Market, by Application

• 9.1. Introduction
• 9.2. Implantable Devices
  • 9.2.1. Cochlear Implants
  • 9.2.2. Defibrillators
  • 9.2.3. Neurostimulators
  • 9.2.4. Pacemakers
• 9.3. Portable Devices
  • 9.3.1. Glucose Monitors
  • 9.3.2. Infusion Pumps
  • 9.3.3. Patient Monitoring Devices
  • 9.3.4. Portable Ultrasound Devices
• 9.4. Stationary Devices
  • 9.4.1. Diagnostic Imaging Equipment
    • 9.4.1.1. Computed Tomography
    • 9.4.1.2. Magnetic Resonance Imaging
    • 9.4.1.3. X Ray Systems
  • 9.4.2. Laboratory Equipment
    • 9.4.2.1. Blood Analyzers
    • 9.4.2.2. DNA Sequencers

10. Batteries for Medical & Healthcare Device Market, by End User

• 10.1. Introduction
• 10.2. Diagnostics Laboratories
• 10.3. Home Healthcare Settings
• 10.4. Hospitals
• 10.5. Research Institutions

11. Batteries for Medical & Healthcare Device Market, by Region

• 11.1. Introduction
• 11.2. Asia-Pacific
• 11.3. North America
• 11.4. Latin America
• 11.5. Europe
• 11.6. Middle East
• 11.7. Africa

12. Batteries for Medical & Healthcare Device Market, by Group

• 12.1. Introduction
• 12.2. ASEAN
• 12.3. GCC
• 12.4. European Union
• 12.5. BRICS
• 12.6. G7
• 12.7. NATO

13. Batteries for Medical & Healthcare Device Market, by Country

• 13.1. Introduction
• 13.2. United States
• 13.3. Canada
• 13.4. Mexico
• 13.5. Brazil
• 13.6. United Kingdom
• 13.7. Germany
• 13.8. France
• 13.9. Russia
• 13.10. Italy
• 13.11. Spain
• 13.12. China
• 13.13. India
• 13.14. Japan
• 13.15. Australia
• 13.16. South Korea

14. Competitive Landscape

• 14.1. Market Share Analysis, 2025
• 14.2. Market Concentration Analysis, 2025
  • 14.2.1. Concentration Ratio (CR)
  • 14.2.2. Herfindahl Hirschman Index (HHI)
• 14.3. Recent Developments & Impact Analysis, 2025
• 14.4. Product Portfolio Analysis, 2025
• 14.5. Benchmarking Analysis, 2025

15. Company Profiles

• 15.1. Duracell U.S. Operations, Inc.
• 15.2. Energizer Holdings, Inc.
• 15.3. EnerSys
• 15.4. GS Yuasa Corporation
• 15.5. LG Energy Solution Ltd
• 15.6. Panasonic Energy Co., Ltd
• 15.7. Renata SA
• 15.8. Saft Groupe SA
• 15.9. Samsung SDI Co., Ltd
• 15.10. Ultralife Corporation
• 15.11. VARTA AG

16. Key Experts